1998
DOI: 10.1097/00005392-199811000-00005
|View full text |Cite
|
Sign up to set email alerts
|

Medical Reduction of Stone Risk in a Network of Treatment Centers Compared to a Research Clinic

Abstract: Given proper software and laboratory support, a network of treatment centers can rival but not quite match results in a dedicated metabolic stone research and prevention clinic. Therefore, large scale stone prevention in a network system appears feasible and effective.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(10 citation statements)
references
References 28 publications
0
10
0
Order By: Relevance
“…The distinction is important because supersaturation is accepted as "the most direct available expression of crystallization potential that one can obtain in clinical practice." 8 The sensitivity and specificity of 24-hour calcium for detecting elevated CaOxSS and CaPhosSS were similar for men and for women. This held true for calcium alone or in combination with oxalate or phosphate.…”
Section: Discussionmentioning
confidence: 85%
See 1 more Smart Citation
“…The distinction is important because supersaturation is accepted as "the most direct available expression of crystallization potential that one can obtain in clinical practice." 8 The sensitivity and specificity of 24-hour calcium for detecting elevated CaOxSS and CaPhosSS were similar for men and for women. This held true for calcium alone or in combination with oxalate or phosphate.…”
Section: Discussionmentioning
confidence: 85%
“…1 This calculation represents the supersaturation ratio, which is the activity product (of calcium and oxalate ions, for instance) divided by the solubility product. 8 …”
Section: Patientsmentioning
confidence: 99%
“…Moreover, stone prevention programs have been proven capable and efficient in several studies with the enrollment of stone formers, which has the potential to lead to the reduction of medical expenditures related to kidney stones disease. [19][20][21][22][23] Finally, the 2016 updated CUA guidelines still categorize metabolic evaluation as grade C Oxford levels of evidence while the 2014 EAU guidelines upgraded the level of evidence regarding metabolic evaluations in highrisk stone formers to a grade A recommendation. [12,14,24] Therefore, quantitative research, randomized clinical trials and cost-effectiveness studies of metabolic evaluations in high-risk and interested first-time stone formers may be warranted to reassess the level of evidence of metabolic evaluations.…”
Section: Harmouch Et Al Adherence To Kidney Stone Evaluation Guidelinesmentioning
confidence: 99%
“…An antimicrobial and a urine volume marker were added to each urine container and then a 50-ml aliquot of urine was obtained. The participants performed the urine collections at home, and then mailed their urine collections to Litholink Corp (Chicago, IL), a commercial laboratory for analysis [12]. Results of individuals in whom 24-h excretion of creatinine varied between collections by 30% or more were judged to have been inaccurately collected and were excluded.…”
Section: Urine Chemistry Analysismentioning
confidence: 99%